Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Ayr Wellness Inc C.AYR.A

Alternate Symbol(s):  AYRWF

AYR Wellness Inc. is a vertically integrated multi-state cannabis operator in the United States. The Company operates simultaneously as a retailer with more than 90 licensed dispensaries and a house of cannabis consumer packed goods (CPG) brands. It is a cultivator, manufacturer and retailer of cannabis products and branded CPG, and is engaged in the manufacture, possession, use, sale, or... see more

CSE:AYR.A - Post Discussion

Ayr Wellness Inc > Ayr Wellness: Canaccord Raises Price Target To $70
View:
Post by AwareInvestor on Mar 15, 2021 9:38am

Ayr Wellness: Canaccord Raises Price Target To $70

On March 10th, Ayr Wellness reported their fourth quarter and year end financial results. They posted quarterly revenues of U$47.76 million, an adjusted EBITDA of U$19.35 million, along with a net loss of U$143.58 million. Full year numbers came in at U$155.1 million, U$56.19 million, and -U$176.3 million, respectively. These numbers generally came in line with the average analyst estimate.
 
Ayr Wellness currently has four analysts covering the company with a weighted 12-month price target of C$58. This is up from the average before the results, which was C$54.60. One analyst has a strong buy rating and the other three have buy ratings. The street high comes from Beacon Securities with a C$76 price target, and the lowest target comes from PI Financial with a C$60 price target.

https://thedeepdive.ca/ayr-wellness-canaccord-raises-price-target-to-70/
Be the first to comment on this post
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities